Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 65/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

31%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

60% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (3)
P 3 (2)
P 4 (2)

Trial Status

Recruiting3
Unknown3
Completed3
Terminated2
Not Yet Recruiting1
Withdrawn1

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT06273098Not ApplicableWithdrawn

School-Based Bladder Health Intervention

NCT05066854Not ApplicableTerminatedPrimary

INterest of the Negative Predictive Value of Integrons in Choosing a Narrow-spectrum Empirical anTibiotic Treatment vs Usual Empirical Antibiotic Treatment for Urinary Tract infectionS in the PEDiatric Emergency Department

NCT03825874Recruiting

Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children

NCT04278404Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT06625554Not Yet RecruitingPrimary

Urinary Tract Infection In Assiut University Children Hospital

NCT05819229RecruitingPrimary

Oral Antibiotics Alone in Children Aged 4 Weeks to 2 Months With a Urinary Tract Infection

NCT06109688Phase 3CompletedPrimary

Effect of Lactoferrin Supplementation on Urinary Tract Infections in Infants.

NCT04654507Phase 3UnknownPrimary

Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children

NCT04763967TerminatedPrimary

A Study of the PedSCath Pediatric Sampling Catheter Versus Current Standard of Care.

NCT04608851Phase 4UnknownPrimary

Preventing Urinary Tract Infections With E. Coli Nissle:

NCT04066621Phase 4Completed

PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)

NCT03221504Not ApplicableUnknownPrimary

7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children

NCT03263845CompletedPrimary

Evaluation of Pain in Urinary Collections in Pediatric Emergencies in Children Who Have Not Acquired Cleanliness

Showing all 13 trials

Research Network

Activity Timeline